-transparent.png){kind=logo}
A panel of CD4+ T-cell clones has been isolated from the spleen and lymph nodes of diabetic NOD mice. These clones have been shown to be islet-specific both in vivo and in vitro. One of the clones, BDC-6.9, initiates extensive damage to islet tissue when placed adjacent to an NOD islet graft that has been used to reverse diabetes in (CBA x NOD)F1 recipients or when injected intraperitoneally into such animals. In this study, we show that BDC-6.9 T cells can initiate islet destruction in the absence of detectable CD8 T cells either in the periphery or in the lesion that develops after the transfer of the cloned islet-reactive T cells.
Related Publications
B J Bradley, and
K Haskins, and
F G La Rosa, and
K J Lafferty
October 2002,
The Journal of experimental medicine,
B J Bradley, and
K Haskins, and
F G La Rosa, and
K J Lafferty
December 2003,
European journal of immunology,
B J Bradley, and
K Haskins, and
F G La Rosa, and
K J Lafferty
January 1992,
Autoimmunity,
B J Bradley, and
K Haskins, and
F G La Rosa, and
K J Lafferty
March 1995,
International immunology,
B J Bradley, and
K Haskins, and
F G La Rosa, and
K J Lafferty
March 1998,
Immunology,
B J Bradley, and
K Haskins, and
F G La Rosa, and
K J Lafferty
April 2016,
Journal of immunology (Baltimore, Md. : 1950),
B J Bradley, and
K Haskins, and
F G La Rosa, and
K J Lafferty
September 2004,
Nature immunology,
B J Bradley, and
K Haskins, and
F G La Rosa, and
K J Lafferty
January 2003,
Parasite immunology,
B J Bradley, and
K Haskins, and
F G La Rosa, and
K J Lafferty
June 2007,
Journal of immunology (Baltimore, Md. : 1950),
B J Bradley, and
K Haskins, and
F G La Rosa, and
K J Lafferty
November 2010,
Journal of immunology (Baltimore, Md. : 1950),
